Home / Pharmacology / Central Nervous System

Tricyclic Antidepressant (TCA) Overdose: Pharmacokinetic Profiling (Toxicology Protocol)

Central Nervous System Specialty Division
â–  LECTURE OVERVIEW: Tricyclic Antidepressant (TCA) overdose is a major toxicological emergency characterized by multi-system receptors blockade. â–  THE CARDIOVASCULAR AND CENTRAL TOXICITIES: 1. Rapid Cardiac Sodium Channel Inactivation: TCAs block fast sodium channels (IKr) in myocardial tissue, slowing Phase 0 of the action potential and prolonging the QRS interval. This drives severe intraventricular conduction delays and lethal ventricular arrhythmias. 2. Anticholinergic Overdrive: Blocks muscarinic (M1) receptors, producing central and peripheral anticholinergic syndrome (altered mental status, dry skin, dilated non-reactive pupils, urinary retention, and hyperthermia). 3. Vascular Collapse: Inhibits alpha-1 adrenergic receptors, preventing peripheral vasoconstriction and causing refractory hypotension. 4. Neuronal Excitability: Blocks GABA-A receptors in the brain, lowering the seizure threshold and precipitating status epilepticus. â–  PHARMACOKINETIC & PHARMACODYNAMIC ATTRIBUTES: Absorption and steady-state kinetics display high variability based on plasma protein binding levels, tissue volume of distribution (Vd), and hepatic CYP450 microsomal enzymatic clearance indices. â–  ACUTE TOXICOLOGICAL PROFILE: High cumulative chemical exposure or accidental overdose triggers systemic receptor overload, cellular injury, and metabolic acidosis. [HY-BOARD-1172]

🌟 Dynamic Clinical Key:

First-line, life-saving treatment is intravenous Sodium Bicarbonate (NaHCO3). The sodium load increases extracellular sodium concentration to overcome the TCA-mediated blockade, while the systemic alkalorization (raising pH to 7.45-7.55) converts the TCA molecule into its neutral, non-ionized form, reducing its affinity for sodium channels. Closely monitor serum plasma concentrations if drugs display a narrow therapeutic window to mitigate toxic peaks. Immediate administration of physiological charcoal or specific receptor antagonists is lifesaving.

Professional Medical Reference Application v2.5

For training, board examinations (USMLE, PLAB), and clinician benchmarking. Do not replace professional care.